Further boosting the pipeline, mid-stage drugs like Sanofi/Regeneron’s itepekimab, AstraZeneca’s benralizumab, Amgen Inc ...

As a wave of patent expirations encroaches upon many of the world’s top drugmakers, companies will need to be diligent in ...

The current US Supreme Court has no fundamental understanding of a range of medical, engineering, technological, or ...

In the wake of the U.S. Supreme Court’s decision in Amgen Inc. v. Sanofi, 598 U.S. 594 (2023) (Amgen), in which the Court addressed whether Amgen’s functional antibody genus claims satisfy the ...

Telangana has attracted 141 life sciences investments totaling 36,000 crore, expected to create 51,000 direct jobs. With a ...

Pfizer, Sanofi and others report Q3 beats; AbbVie, Roche and Novartis strike big deals; the 2024 presidential election looms; ...

Amgen releases Phase 3 trial data for rocatinlimab ... Vandana Singh Private Equity Firms Circle Sanofi's Consumer Health Business Amid Potential Spinoff Sanofi plans to spin off its consumer ...

Telangana has secured Rs 36,000 crore in life sciences investments over the past year, attracting major global companies and ...

DelveInsight's Dermatological Drugs Market Insights report provides the current and forecast market analysis, individual ...